Who are the key players in the Anthim Market Report 2026 market?

Major companies operating in the Anthim Market Report 2026 market are Major companies operating in the anthim market are Elusys Therapeutics Inc, Hikma Pharmaceuticals Read More

What are the major opportunities in the Anthim market? What are the strategies for the Anthim market?

For detailed insights on the major opportunities and strategies in the Anthim market, Read More

How does the Anthim market relate to the overall economy and other similar markets?

For detailed insights on Anthim's relation to the overall economy and other similar markets, Read More

What are the latest mergers and acquisitions in the Anthim industry?

For detailed insights on the mergers and acquisitions in the Anthim industry, Read More

What are the key dynamics influencing the Anthim market growth? SWOT analysis of the Anthim market.

For detailed insights on the key dynamics influencing the Anthim market growth and SWOT analysis of the Anthim industry, Read More

Anthim Market Global Report 2026 Market Report Infographic Image

Published : March 2026

Pages :

Format : PDF

Delivery Time : 2-3 Business Days

Report Price : $4490.00

Anthim Market Report 2026

Name: Anthim Market Report 2026
Brand: The Business Research Company
Price: 4490.00 USD
Availability: InStock

Epidemiology, Pipeline Analysis, Market Insights & Forecasts

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

Purchase This Report Download Sample PDF

Item added to cart!

Anthim Market Overview

• The Anthim market growth in the historic period has been driven by bioterrorism preparedness initiatives, government funding for biodefense

• Market expansion is supported by continued biodefense investment, rising focus on pandemic and biosecurity readiness

• Growth Driver: Impact Of Rising Bacterial Disease Prevalence On The Growth Of The ANTHIM Market

• North America was the largest region in 2025 and Asia Pacific is the fastest growing region.

What Is Covered Under Anthim Market?

Anthim is a monoclonal antibody used to treat inhalational anthrax caused by Bacillus anthracis infection. It works by binding to the anthrax toxin, preventing it from entering cells and causing damage.

The main types of anthim are adult and children. Anthim (obiltoxaximab) is indicated for use in adults as part of the treatment regimen for inhalational anthrax caused by Bacillus anthracis. The incical indication involved are inhalational anthrax treatment, post-exposure prophylaxis (pep) for inhalational anthrax, use in pediatric and adult population. The various applications involved are hospital, drugs store, and other applications.

Anthim Market Global Report 2026 Market Report bar graph

What Is The Anthim Market Size and Share 2026?

The anthim market size has grown strongly in recent years. It will grow from $4.3 million in 2025 to $4.63 million in 2026 at a compound annual growth rate (CAGR) of 7.6%. The growth in the historic period can be attributed to bioterrorism preparedness initiatives, government funding for biodefense, proven efficacy of monoclonal antibody therapies, strategic national stockpile programs, regulatory approvals for emergency use.

What Is The Anthim Market Growth Forecast?

The anthim market size is expected to see strong growth in the next few years. It will grow to $6.13 million in 2030 at a compound annual growth rate (CAGR) of 7.3%. The growth in the forecast period can be attributed to continued biodefense investment, rising focus on pandemic and biosecurity readiness, expansion of emergency response infrastructure, technological advances in antibody production, long term government procurement contracts. Major trends in the forecast period include increased stockpiling of anthrax countermeasures, growing government preparedness programs, rising use of monoclonal antibodies in biodefense, expansion of emergency response treatment protocols, enhanced focus on rapid deployment therapies.

Book your 30 minutes free consultation with our research experts

Global Anthim Market Segmentation

1) By Type: Adult, Children

2) By Clinical Indications: Inhalational Anthrax Treatment, Post-Exposure Prophylaxis (PEP) For Inhalational Anthrax, Use In Pediatric And Adult Populations

3) By Application: Hospital, Drugs Store, Other Applications

What Are The Drivers Of The Anthim Market?

The rising prevalence of bacterial infections is expected to propel the growth of the anthim market going forward. Bacterial infections refer to diseases caused by harmful bacteria that invade the body, multiply, and produce toxins. The rise in bacterial infections stems from antibiotic overuse, global travel, urbanization, poor hygiene, and healthcare-associated infections. Anthim (obiltoxaximab) is used to treat anthrax, a bacterial infection caused by Bacillus anthracis, by neutralizing the anthrax toxin and preventing it from entering cells, thereby mitigating its harmful effects. For instance, in December 2023, according to report published by World Health Organization (WHO), a Switzerland-based health authority, suspected anthrax cases in Zambia rose from 42 between September 2022 and January 2023 to 684 by November 20, 2023, including four deaths (0.6% CFR), across 44 districts in nine of the country's ten provinces. Therefore, the rising prevalence of bacterial infections is driving the growth of the anthim industry.

Anthim Market Driver: Surge In Chronic Diseases Fueling The Growth Of The Market Due To Rising Demand For Long-Term Targeted Therapeutic Solutions
The rising chronic disease is expected to propel the growth of the anthim market going forward. A chronic disease is a long-lasting health condition that progresses slowly and usually persists for years. Chronic diseases are increasing mainly due to unhealthy lifestyle habits such as poor diet and physical inactivity. Anthim is used to treat chronic conditions by providing targeted therapeutic effects that help reduce disease progression and improve long-term health outcomes. For instance, in June 2023, the Institute for Health Metrics and Evaluation, a US-based public health research institute, reported that over half a billion people globally were living with diabetes. This number is expected to more than double, reaching 1.3 billion people by 2050. Therefore, the rising chronic disease will drive the growth of the anthim market.
The rising healthcare expenditure is expected to drive the growth of the anthim market going forward. Healthcare expenditure is the total spending on medical services, treatments, and healthcare resources, funded by governments, insurers, and individuals to ensure accessible and quality care. Healthcare expenditure is increasing mainly due to the growing burden of chronic and lifestyle-related diseases. Anthim benefits from rising healthcare expenditure as increased funding enables broader access to advanced therapies. For instance, In May 2024, according to the Office for National Statistics, a UK-based government department, reported that total healthcare expenditure saw a 5.6% increase in nominal terms from 2022 to 2023, marking a significant acceleration compared to the 0.9% growth observed in 2022. Therefore, the rising healthcare expenditure is driving the growth of the entecavir market.

Key Players In The Global Anthim Market

Major companies operating in the anthim market are Elusys Therapeutics Inc, Hikma Pharmaceuticals

Need data on a specific region in this market?

Request Regional Data

Regional Insights

North America was the largest region in the anthim market in 2025. Asia Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in this market report are Australia, India, China, South Korea, Japan, UK, France, Germany, USA, Canada.

What Defines the Anthim Market?

The anthim market consists of sales of monoclonal antibodies, injectable solutions and emergency response treatments. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Anthim Market Report 2026?

The anthim market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the anthim industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.

Author : Abhilash Pyata

Anthim Market Report Forecast Analysis

Report Attribute	Details
Market Size Value In 2026	$ billion
Revenue Forecast In 2035	$ billion
Growth Rate	CAGR of 7.6% from 2026 to 2035
Base Year For Estimation	2025
Actual Estimates/Historical Data	2020-2025
Forecast Period	2026 - 2030 - 2035
Market Representation	Revenue in USD Billion and CAGR from 2026 to 2035
Segments Covered	Type, Clinical Indications, Application
Regional Scope	Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope	The countries covered in the report are Australia, Brazil, China, France, Germany, India, ...
Key Companies Profiled	Elusys Therapeutics Inc, Hikma Pharmaceuticals
Customization Scope	Request for Customization
Pricing And Purchase Options	Explore Purchase Options

1. Executive Summary

1.1. Key Market Insights (2020-2035)

1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots

1.3. Major Factors Driving the Market

1.4. Top Three Trends Shaping the Market

2. Anthim Market Characteristics

2.1. Market Definition & Scope

2.2. Market Segmentations

2.3. Overview of Key Products and Services

2.4. Global Anthim Market Attractiveness Scoring And Analysis

2.4.1. Overview of Market Attractiveness Framework

2.4.2. Quantitative Scoring Methodology

2.4.3. Factor-Wise Evaluation

Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation

2.4.4. Market Attractiveness Scoring and Interpretation

2.4.5. Strategic Implications and Recommendations

3. Anthim Market Supply Chain Analysis

3.1. Overview of the Supply Chain and Ecosystem

3.2. List Of Key Raw Materials, Resources & Suppliers

3.3. List Of Major Distributors and Channel Partners

3.4. List Of Major End Users

4. Global Anthim Market Trends And Strategies

4.1. Key Technologies & Future Trends

4.1.1 Biotechnology, Genomics & Precision Medicine

4.1.2 Artificial Intelligence & Autonomous Intelligence

4.1.3 Digitalization, Cloud, Big Data & Cybersecurity

4.1.4 Sustainability, Climate Tech & Circular Economy

4.1.5 Industry 4.0 & Intelligent Manufacturing

4.2. Major Trends

4.2.1 Increased Stockpiling Of Anthrax Countermeasures

4.2.2 Growing Government Preparedness Programs

4.2.3 Rising Use Of Monoclonal Antibodies In Biodefense

4.2.4 Expansion Of Emergency Response Treatment Protocols

4.2.5 Enhanced Focus On Rapid Deployment Therapies

5. Anthim Market Analysis Of End Use Industries

5.1 Hospitals

5.2 Government Health Agencies

5.3 Emergency Response Units

5.4 Military Medical Facilities

5.5 Public Health Institutions

6. Anthim Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Anthim Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

7.1. Global Anthim PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

7.2. Global Anthim Market Size, Comparisons And Growth Rate Analysis

7.3. Global Anthim Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)

7.4. Global Anthim Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Anthim Total Addressable Market (TAM) Analysis for the Market

8.1. Definition and Scope of Total Addressable Market (TAM)

8.2. Methodology and Assumptions

8.3. Global Total Addressable Market (TAM) Estimation

8.4. TAM vs. Current Market Size Analysis

8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Anthim Market Segmentation

9.1. Global Anthim Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Adult, Children

9.2. Global Anthim Market, Segmentation By Clinical Indications, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Inhalational Anthrax Treatment, Post-Exposure Prophylaxis (PEP) For Inhalational Anthrax, Use In Pediatric And Adult Populations

9.3. Global Anthim Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Hospital, Drugs Store, Other Applications

10. Anthim Market Regional And Country Analysis

10.1. Global Anthim Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

10.2. Global Anthim Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Anthim Market

11.1. Asia-Pacific Anthim Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

11.2. Asia-Pacific Anthim Market, Segmentation By Type, Segmentation By Clinical Indications, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Anthim Market

12.1. China Anthim Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

12.2. China Anthim Market, Segmentation By Type, Segmentation By Clinical Indications, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Anthim Market

13.1. India Anthim Market, Segmentation By Type, Segmentation By Clinical Indications, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Anthim Market

14.1. Japan Anthim Market Overview

14.2. Japan Anthim Market, Segmentation By Type, Segmentation By Clinical Indications, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Anthim Market

15.1. Australia Anthim Market, Segmentation By Type, Segmentation By Clinical Indications, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. South Korea Anthim Market

16.1. South Korea Anthim Market Overview

16.2. South Korea Anthim Market, Segmentation By Type, Segmentation By Clinical Indications, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. Western Europe Anthim Market

17.1. Western Europe Anthim Market Overview

17.2. Western Europe Anthim Market, Segmentation By Type, Segmentation By Clinical Indications, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. UK Anthim Market

18.1. UK Anthim Market, Segmentation By Type, Segmentation By Clinical Indications, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. Germany Anthim Market

19.1. Germany Anthim Market, Segmentation By Type, Segmentation By Clinical Indications, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. France Anthim Market

20.1. France Anthim Market, Segmentation By Type, Segmentation By Clinical Indications, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. Eastern Europe Anthim Market

21.1. Eastern Europe Anthim Market Overview

21.2. Eastern Europe Anthim Market, Segmentation By Type, Segmentation By Clinical Indications, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. North America Anthim Market

22.1. North America Anthim Market Overview

22.2. North America Anthim Market, Segmentation By Type, Segmentation By Clinical Indications, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. USA Anthim Market

23.1. USA Anthim Market Overview

23.2. USA Anthim Market, Segmentation By Type, Segmentation By Clinical Indications, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Canada Anthim Market

24.1. Canada Anthim Market Overview

24.2. Canada Anthim Market, Segmentation By Type, Segmentation By Clinical Indications, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. South America Anthim Market

25.1. South America Anthim Market Overview

25.2. South America Anthim Market, Segmentation By Type, Segmentation By Clinical Indications, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Middle East Anthim Market

26.1. Middle East Anthim Market Overview

26.2. Middle East Anthim Market, Segmentation By Type, Segmentation By Clinical Indications, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Africa Anthim Market

27.1. Africa Anthim Market Overview

27.2. Africa Anthim Market, Segmentation By Type, Segmentation By Clinical Indications, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. Anthim Market Regulatory and Investment Landscape

29. Anthim Market Competitive Landscape And Company Profiles

29.1. Anthim Market Competitive Landscape And Market Share 2024

29.1.1. Top 10 Companies (Ranked by revenue/share)

29.2. Anthim Market - Company Scoring Matrix

29.2.1. Market Revenues

29.2.2. Product Innovation Score

29.2.3. Brand Recognition

29.3. Anthim Market Company Profiles

29.3.1. Elusys Therapeutics Inc Overview, Products and Services, Strategy and Financial Analysis

29.3.2. Hikma Pharmaceuticals Overview, Products and Services, Strategy and Financial Analysis

30. Global Anthim Market Competitive Benchmarking And Dashboard

31. Key Mergers And Acquisitions In The Anthim Market

32. Anthim Market High Potential Countries, Segments and Strategies

32.1 Anthim Market In 2030 - Countries Offering Most New Opportunities

32.2 Anthim Market In 2030 - Segments Offering Most New Opportunities

32.3 Anthim Market In 2030 - Growth Strategies

32.3.1 Market Trend Based Strategies

32.3.2 Competitor Strategies

33. Appendix

33.1. Abbreviations

33.2. Currencies

33.3. Historic And Forecast Inflation Rates

33.4. Research Inquiries

33.5. The Business Research Company

33.6. Copyright And Disclaimer

List Of Tables

Table 1: Global Anthim Market, Overview Of Key Products - Product Examples

Table 2: Global Anthim Market Attractiveness, Factor-Wise Evaluation

Table 3: Global Anthim Market, Supply Chain Analysis

Table 4: Global Anthim Market, Major Raw Material Providers

Table 5: Global Anthim Market, Major Resource Providers

Table 6: Global Anthim Market, Major Manufacturers (Suppliers)

Table 7: Global Anthim Market, Major Distributors And Channel Partners

Table 8: Global Anthim Market, Key Technologies & Future Trends

Table 9: Global Anthim Market, Major Trends

Table 10: Global Anthim Market, Major End Users

Table 11: Global Anthim Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis

Table 12: Global Anthim Historic Market Growth, 2020-2025, $ Billion

Table 13: Global Anthim Forecast Market Growth, 2025-2030F, 2035F, $ Billion

Table 14: Global Anthim Market - TAM, US$ Billion, 2025

Table 15: Global Anthim Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 16: Global Anthim Market, Segmentation By Clinical Indications, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 17: Global Anthim Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 18: Global Anthim Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 19: Global Anthim Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 20: Asia-Pacific, Anthim Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 21: Asia-Pacific, Anthim Market, Segmentation By Clinical Indications, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 22: Asia-Pacific, Anthim Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 23: China, Anthim Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 24: China, Anthim Market, Segmentation By Clinical Indications, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 25: China, Anthim Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 26: India, Anthim Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 27: India, Anthim Market, Segmentation By Clinical Indications, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 28: India, Anthim Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 29: Japan, Anthim Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 30: Japan, Anthim Market, Segmentation By Clinical Indications, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 31: Japan, Anthim Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 32: Australia, Anthim Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 33: Australia, Anthim Market, Segmentation By Clinical Indications, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 34: Australia, Anthim Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 35: South Korea, Anthim Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 36: South Korea, Anthim Market, Segmentation By Clinical Indications, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 37: South Korea, Anthim Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 38: Western Europe, Anthim Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 39: Western Europe, Anthim Market, Segmentation By Clinical Indications, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 40: Western Europe, Anthim Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 41: UK, Anthim Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 42: UK, Anthim Market, Segmentation By Clinical Indications, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 43: UK, Anthim Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 44: Germany, Anthim Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 45: Germany, Anthim Market, Segmentation By Clinical Indications, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 46: Germany, Anthim Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 47: France, Anthim Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 48: France, Anthim Market, Segmentation By Clinical Indications, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 49: France, Anthim Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 50: Eastern Europe, Anthim Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 51: Eastern Europe, Anthim Market, Segmentation By Clinical Indications, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 52: Eastern Europe, Anthim Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 53: North America, Anthim Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 54: North America, Anthim Market, Segmentation By Clinical Indications, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 55: North America, Anthim Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 56: USA, Anthim Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 57: USA, Anthim Market, Segmentation By Clinical Indications, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 58: USA, Anthim Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 59: Canada, Anthim Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 60: Canada, Anthim Market, Segmentation By Clinical Indications, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 61: Canada, Anthim Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 62: South America, Anthim Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 63: South America, Anthim Market, Segmentation By Clinical Indications, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 64: South America, Anthim Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 65: Middle East, Anthim Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 66: Middle East, Anthim Market, Segmentation By Clinical Indications, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 67: Middle East, Anthim Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 68: Africa, Anthim Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 69: Africa, Anthim Market, Segmentation By Clinical Indications, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 70: Africa, Anthim Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 71: Global Anthim Key Competitor Estimated Market Shares, 2024, Percentage (%)

Table 72: Global Anthim Market - Company Scoring Matrix

Table 73: Elusys Therapeutics Inc Financial Performance

Table 74: Hikma Pharmaceuticals Financial Performance

Table 75: Global Anthim Market, Competitive Benchmarking (In USD Billions)

Table 76: Global Anthim Market, Competitive Dashboard

Table 77: Global Anthim Market Size Gain ($ Billion), 2025 – 2030 By Country

Table 78: Global, Anthim Market Size Gain ($ Billion), Segmentation By Type, 2025 – 2030

Table 79: Global, Anthim Market Size Gain ($ Billion), Segmentation By Clinical Indications, 2025 – 2030

Table 80: Global, Anthim Market Size Gain ($ Billion), Segmentation By Application, 2025 – 2030

List Of Figures

Figure 1: Global Anthim Market, Overview Of Key Products - Product Examples

Figure 2: Global Anthim Market Attractiveness, Factor-Wise Evaluation

Figure 3: Global Anthim Market, Supply Chain Analysis

Figure 4: Global Anthim Market, Major Raw Material Providers

Figure 5: Global Anthim Market, Major Resource Providers

Figure 6: Global Anthim Market, Major Manufacturers (Suppliers)

Figure 7: Global Anthim Market, Major Distributors And Channel Partners

Figure 8: Global Anthim Market, Key Technologies & Future Trends

Figure 9: Global Anthim Market, Major Trends

Figure 10: Global Anthim Market, Major End Users

Figure 11: Global Anthim Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis

Figure 12: Global Anthim Historic Market Growth, 2020-2025, $ Billion

Figure 13: Global Anthim Forecast Market Growth, 2025-2030F, 2035F, $ Billion

Figure 14: Global Anthim Market - TAM, US$ Billion, 2025

Figure 15: Global Anthim Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 16: Global Anthim Market, Segmentation By Clinical Indications, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 17: Global Anthim Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 18: Global Anthim Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 19: Global Anthim Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 20: Asia-Pacific, Anthim Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 21: Asia-Pacific, Anthim Market, Segmentation By Clinical Indications, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 22: Asia-Pacific, Anthim Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 23: China, Anthim Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 24: China, Anthim Market, Segmentation By Clinical Indications, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 25: China, Anthim Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 26: India, Anthim Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 27: India, Anthim Market, Segmentation By Clinical Indications, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 28: India, Anthim Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 29: Japan, Anthim Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 30: Japan, Anthim Market, Segmentation By Clinical Indications, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 31: Japan, Anthim Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 32: Australia, Anthim Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 33: Australia, Anthim Market, Segmentation By Clinical Indications, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 34: Australia, Anthim Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 35: South Korea, Anthim Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 36: South Korea, Anthim Market, Segmentation By Clinical Indications, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 37: South Korea, Anthim Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 38: Western Europe, Anthim Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 39: Western Europe, Anthim Market, Segmentation By Clinical Indications, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 40: Western Europe, Anthim Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 41: UK, Anthim Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 42: UK, Anthim Market, Segmentation By Clinical Indications, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 43: UK, Anthim Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 44: Germany, Anthim Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 45: Germany, Anthim Market, Segmentation By Clinical Indications, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 46: Germany, Anthim Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 47: France, Anthim Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 48: France, Anthim Market, Segmentation By Clinical Indications, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 49: France, Anthim Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 50: Eastern Europe, Anthim Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 51: Eastern Europe, Anthim Market, Segmentation By Clinical Indications, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 52: Eastern Europe, Anthim Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 53: North America, Anthim Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 54: North America, Anthim Market, Segmentation By Clinical Indications, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 55: North America, Anthim Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 56: USA, Anthim Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 57: USA, Anthim Market, Segmentation By Clinical Indications, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 58: USA, Anthim Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 59: Canada, Anthim Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 60: Canada, Anthim Market, Segmentation By Clinical Indications, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 61: Canada, Anthim Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 62: South America, Anthim Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 63: South America, Anthim Market, Segmentation By Clinical Indications, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 64: South America, Anthim Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 65: Middle East, Anthim Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 66: Middle East, Anthim Market, Segmentation By Clinical Indications, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 67: Middle East, Anthim Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 68: Africa, Anthim Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 69: Africa, Anthim Market, Segmentation By Clinical Indications, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 70: Africa, Anthim Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 71: Global Anthim Key Competitor Estimated Market Shares, 2024, Percentage (%)

Figure 72: Global Anthim Market - Company Scoring Matrix

Figure 73: Elusys Therapeutics Inc Financial Performance

Figure 74: Hikma Pharmaceuticals Financial Performance

Figure 75: Global Anthim Market, Competitive Benchmarking (In USD Billions)

Figure 76: Global Anthim Market, Competitive Dashboard

Figure 77: Global Anthim Market Size Gain ($ Billion), 2025 – 2030 By Country

Figure 78: Global, Anthim Market Size Gain ($ Billion), Segmentation By Type, 2025 – 2030

Figure 79: Global, Anthim Market Size Gain ($ Billion), Segmentation By Clinical Indications, 2025 – 2030

Figure 80: Global, Anthim Market Size Gain ($ Billion), Segmentation By Application, 2025 – 2030

Advanced Therapy Medicinal Products Industry Poised for Rapid Expansion, Projected to Hit $104.43 Billion by 2029

Global Insights: Androgen Deprivation Therapy Market Expected to Surpass $10.49 Billion by 2029

2025 Anti-CD20 Monoclonal Antibodies Market Outlook: Opportunities, Growth Trends, and Strategic Analysis

Future Projections: Anti-D Immunoglobulin Market to Reach $3.34 Billion by 2029 at 6.6% CAGR

Anti-Inflammatory Biologics Market Revenue Outlook: Strategic Insights and Forecast to 2029

CAGR of 10.8% Projected for Anti-Tumor Drugs Market From 2025 to 2029

Future Demand and Leading Companies Shaping the Asthma Disease Market to 2029

Comprehensive Forecast: Asthma Therapeutics Market Share, Growth, and Opportunities Through 2029

Market Research Services Market Report 2026 - Global Outlook – By Type (Marketing Research And Analysis Services, Public Opinion And Election Polling), By Research Methodology (Qualitative Research, Quantitative Research...

Auto Finance Market Report 2026 - Global Outlook – By Finance (Direct, Indirect), By Vehicle Age (New Vehicles, Used Vehicles), By Loan Provider (Banks, Original Equipment Manufacturer (OEM), Credit Unions, Other Loan Pr...

Direct Selling Market Report 2026 - Global Outlook – By Type (Single-Level Marketing, Multi-Level Marketing), By Application (Wellness, Cosmetics, Household Goods, Other Applications), By End-User (Individual Customers, ...

Insurance Advertising Market Report 2026 - Global Outlook – By Type (Life Insurance, Non-Health Insurance), By Advertisement Channels (Television, Email, Sales Calls, Other Advertisement Channels), By Application (Direct...

Data Lake Market Report 2026 - Global Outlook – By Type (Solution, Services), By Deployment (On-Premise, Cloud), By Organization Size (Large Enterprises, Small And Medium-Sized Enterprises (SMEs)), By Vertical (Informati...

Trade Finance Market Report 2026 - Global Outlook – By Type (Supply Chain Finance, Structured Trade Finance, Traditional Trade Finance), By Service Provider (Banks, Financial Institutions, Trading Houses, Other Services)...

Vertical Market Software Market Report 2026 - Global Outlook – By Software Type (Banking Software, Education Software, Legal Software, Agriculture Software, Alumni Management Software, Amusement Park Software, Apparel So...

Frequently Asked Questions

How big is the Anthim Market?

The Anthim market was valued at $ billion in 2025, increased to $ billion in 2026, and is projected to reach $ billion by 2030.

What is the Anthim market growth?

The global Anthim market is expected to grow at a CAGR of 7.3% from 2026 to 2035 to reach $ billion by 2035.

Who are the key players in Anthim market?

Some Key Players in the Anthim market Include, Elusys Therapeutics Inc, Hikma Pharmaceuticals .

What is the anticipated growth trend for the Anthim market?

Major trend in this market includes: nan. For further insights on this market. request a sample here

Which region has the most growth potential in the Anthim market?

North America was the largest region in the anthim market in 2025. Asia Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the anthim market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.